128 related articles for article (PubMed ID: 36095278)
1. Practice Patterns for Mohs Surgeons of Varying Clinical Experience: A Cross-Sectional Analysis of a Medicare Claims Database.
Singh P; Smith FL; Brown MD
Dermatol Surg; 2022 Oct; 48(10):1029-1032. PubMed ID: 36095278
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Opioid Prescriptions by Mohs Surgeons in the Medicare Population.
Feng H; Kakpovbia E; Petriceks AP; Feng PW; Geronemus RG
Dermatol Surg; 2020 Mar; 46(3):335-340. PubMed ID: 31356436
[TBL] [Abstract][Full Text] [Related]
3. Trends in Medicare Billing Among Mohs Surgeons in the United States During 2012: A Retrospective Cohort Study.
Tsai S; Kooistra LJ; Conic RZ; Bordeaux JS
Dermatol Surg; 2019 Feb; 45(2):268-273. PubMed ID: 30199438
[TBL] [Abstract][Full Text] [Related]
4. Association Between Surgeon-Specific Features and Number of Stages, Flaps, and Grafts in Mohs Micrographic Surgery: A Retrospective Observational Study of 59 Early-, Mid-, and Advanced-Career Mohs Surgeons.
Alhaddad M; Zade J; Nabatian A; Kriegel D; Khorasani H
Dermatol Surg; 2017 Nov; 43(11):1358-1362. PubMed ID: 28538031
[TBL] [Abstract][Full Text] [Related]
5. Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution.
Krishnan A; Xu T; Hutfless S; Park A; Stasko T; Vidimos AT; Leshin B; Coldiron BM; Bennett RG; Marks VJ; Brandt R; Makary MA; Albertini JG;
JAMA Dermatol; 2017 Jun; 153(6):565-570. PubMed ID: 28453605
[TBL] [Abstract][Full Text] [Related]
6. Rates of Opioid Prescriptions Obtained After Mohs Surgery: A Claims Database Analysis From 2009 to 2020.
Veerabagu SA; Cheng B; Wang S; Etzkorn JR; Kilaru AS; Noe MH; Miller CJ; Sobanko JF; Shin TM; Higgins HW; McMurray SL; Krausz AE; Walker JL; Giordano CN
JAMA Dermatol; 2021 Nov; 157(11):1299-1305. PubMed ID: 34550299
[TBL] [Abstract][Full Text] [Related]
7. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
8. Surgical Volume of Dermatologists Who Do Not Perform Mohs Micrographic Dermatologic Surgery: A Cross-Sectional Individual-Level Analysis Using Medicare Data.
Kantor J
Dermatol Surg; 2020 Jan; 46(1):1-6. PubMed ID: 31188146
[TBL] [Abstract][Full Text] [Related]
9. MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.
Sharma AN; Peterman N; Juhasz M; Shive M
Arch Dermatol Res; 2023 Dec; 316(1):21. PubMed ID: 38060044
[TBL] [Abstract][Full Text] [Related]
10. Micrographic dermatologic surgery (MDS) diplomates: a demographic evaluation and comparison of Medicare case volume.
Walocko FM; Memon R; Kwasny MJ
Arch Dermatol Res; 2022 Mar; 314(2):213-216. PubMed ID: 35133478
[TBL] [Abstract][Full Text] [Related]
11. Association between type of reconstruction after Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study.
Alam M; Helenowksi IB; Cohen JL; Levy R; Liégeois N; Mafong EA; Mooney MA; Nehal KS; Nguyen TH; Ratner D; Rohrer T; Schmults CD; Tan S; Yoon J; Kakar R; Rademaker AW; White LE; Yoo S
Dermatol Surg; 2013 Jan; 39(1 Pt 1):51-5. PubMed ID: 23199073
[TBL] [Abstract][Full Text] [Related]
12. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons.
Alam M; Berg D; Bhatia A; Cohen JL; Hale EK; Herman AR; Huang CC; Jiang SI; Kimyai-Asadi A; Lee KK; Levy R; Rademaker AW; White LE; Yoo SS
Dermatol Surg; 2010 Dec; 36(12):1915-20. PubMed ID: 21040123
[TBL] [Abstract][Full Text] [Related]
13. Mohs micrographic surgery utilization in the Medicare population, 2009.
Donaldson MR; Coldiron BM
Dermatol Surg; 2012 Sep; 38(9):1427-34. PubMed ID: 22681892
[TBL] [Abstract][Full Text] [Related]
14. Quantifying Utilization of Skin Substitutes by Mohs Micrographic Surgeons: A Cross-Sectional Analysis of Medicare Data.
Castner NB; Slutsky JB
Dermatol Surg; 2021 Nov; 47(11):1505-1506. PubMed ID: 34417385
[No Abstract] [Full Text] [Related]
15. Antibiotic Practices in Mohs Micrographic Surgery.
Lin MJ; Dubin DP; Giordano CN; Kriegel DA; Khorasani H
J Drugs Dermatol; 2020 May; 19(5):493-497. PubMed ID: 32484626
[TBL] [Abstract][Full Text] [Related]
16. Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.
Johnstone C; Joiner KA; Pierce J; Krouse RS
Am J Clin Oncol; 2018 Dec; 41(12):1199-1203. PubMed ID: 29672366
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and comorbidities of Medicare beneficiaries receiving care from Mohs micrographic surgeons based on fellowship training and practice setting.
Gronbeck C; Feng H
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755958
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons From 2012-2017.
Patel P; Guzman AK; Tinklepaugh A; Ciocon D
J Drugs Dermatol; 2021 Aug; 20(8):905-906. PubMed ID: 34397191
[TBL] [Abstract][Full Text] [Related]
19. Opioid prescribing patterns after Mohs micrographic surgery and standard excision: a survey of American Society for Dermatologic Surgery members and a chart review at a single institution.
Harris K; Calder S; Larsen B; Duffy K; Bowen G; Tristani-Firouzi P; Hadley M; Endo J
Dermatol Surg; 2014 Aug; 40(8):906-11. PubMed ID: 25022709
[TBL] [Abstract][Full Text] [Related]
20. Mohs Surgeons Dominate Cutaneous Reconstructions in Cosmetically and Functionally Sensitive Sites: Medicare Trends From 2013 to 2019.
Tan A; Castner NB; Slutsky JB
Dermatol Surg; 2023 Jun; 49(6):539-543. PubMed ID: 37000985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
